Evidence map›Paper›PMID 32039047›Full record

ArticleFrontiers in cellular and infection microbiology2019

Generation and Characterization of a Dual-Reporter Transgenic

Rohit Sharma, Paulo S Silveira-Mattos, Vinicius C Ferreira, Francys A Rangel, Laíse B Oliveira, Fabiana S Celes, Sayonara M Viana, Mary E Wilson, Camila I de Oliveira

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Efficient and Stable Subcellular Protein Labeling inPathogens (Basel, Switzerland) · 2026
    Article
  3. Reporter genes and transgenicFrontiers in medicine · 2025
    Review
  4. Reporter gene systems: A powerful tool forCurrent research in microbial sciences · 2022
    Article
  5. Challenges and Tools for In VitroPathogens (Basel, Switzerland) · 2021
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rohit SharmaInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Paulo S Silveira-MattosInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Vinicius C FerreiraInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Francys A RangelInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Laíse B OliveiraInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Fabiana S CelesInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Sayonara M VianaInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.
Mary E WilsonDepartments of Microbiology and Immunology and Internal Medicine, University of Iowa, and the Veterans' Affairs Medical Center, Iowa City, IA, United States.
Camila I de OliveiraInstituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.

Funding

Protective Immunity to Leishmania chagasiR01AI045540 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY E · 2001 to 2011
$3.1M
Genetic Risk Factors for Visceral LeishmaniasisR01AI076233 · NIAID · UNIVERSITY OF IOWA · PI BLACKWELL, JENEFER MARY, WILSON, MARY E · 2009 to 2013
$1.6M
BLRD VA I01 BX000536BLRD VA I01 BX001983NIAID NIH HHS R01 AI045540NIAID NIH HHS R01 AI076233
6 · The paper itself

Abstract

In this study, we generated a transgenic strain of

Indexed as

Genes, ReporterAnimalsDisease Models, AnimalGenomic InstabilityGreen Fluorescent ProteinsLeishmania braziliensisLeishmaniasis, CutaneousLuciferasesLuminescent AgentsMice, Inbred BALB CRecombinant ProteinsStaining and Labelingenhanced green fluorescent proteinGreen Fluorescent ProteinsLuciferasesLuminescent AgentsRecombinant Proteinsdual reporterseGFPL. braziliensisluciferasetransgenic

Identifiers

PMID32039047
PMCPMC6987073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.